Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

This is where diet pills and weight loss supplements can come in handy. However, with so many options available, it's essential to choose the right one for you. Some products offer promising ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Lord Alli funded at least seven Cabinet ministers in a years-long campaign to reshape the Labour Party, The Telegraph can disclose. The Labour peer has handed out £314,147 to members of Sir Keir ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Lord Waheed Alli has always enjoyed picking winners, whether in the worlds of finance, media and fashion ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

Sir Keir Starmer repeatedly used an £18 million penthouse owned by the top Labour donor Lord Alli while campaigning to enter No 10, The Telegraph understands. It is understood the 5,000 sq ft ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers ...

Visible only for a split second before the camera panned away was a rarely seen peer with outsize influence: Waheed Alli. Until recent weeks, most of the British public had never heard of Alli ...

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk (NVO) and Eli Lilly (LLY) by introducing GLP-1 pills.